Table 4 Clinical and pathological characteristics of pre-chemotherapy cluster B immune cell profile
Characteristic | Profile A and C % | Profile B % | P (χ 2) | |
|---|---|---|---|---|
Age | <50 years | 86 | 13 | 0.21 |
≥50 years | 73 | 27 | ||
HER2 | Negative | 81 | 19 | 0.19 |
Positive | 66 | 33 | ||
Hormone- sensitivity | No | 64 | 36 | 0.06 |
Yes | 83 | 17 | ||
IHC subtype | HR+/HER2- | 84 | 16 | 0.15 |
HR+/HER+ | 82 | 18 | ||
HR-/HER2+ | 50 | 50 | ||
HR-/HER2- | 73 | 27 | ||
Grade | G1-2 | 87 | 13 | 0.03 |
G3 | 65 | 35 | ||
cN | cN0-1 | 81 | 19 | 0.24 |
cN2-3 | 69 | 31 | ||
cT | cT1-2 | 77 | 23 | 0.95 |
cT3-4 | 77 | 23 |